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A 569 bp probe against the /?-chain of hepatotropin was used to examine expression of RNA for this growth factor in human adult and foetal 
liver, foetal kidney and pancreas, and rat liver after partial hepatectomy. Low level expression of a 6 kb RNA occurred in human adult and normal 
rat liver. 70% hepatectomy increased expression, peaking at 10 hand returning to near normal levels 24 h after resection. The 6 kb band was strongly 
expressed in human foetal liver, as compared with adult, but not in foetal kidney or pancreas, suggesting a major role for hepatotropin in both 
foetal development and regeneration of the liver. 
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1. INTRODUCTION 
Hepatotropin was first described in rat serum in 
1984, by Nakamura et al. [1,2], as a growth factor 
which induced proliferation in cultures of adult rat 
hepatocytes in vitro and whose concentration rose after 
partial hepatectomy. We described a similar substance 
in normal human serum, and demonstrated a dramatic 
increase in its activity in the serum of patients who had 
undergone a hepatic resection for liver tumours [3]: a 
similar activity was described in serum of patients with 
fulminant hepatic failure [4]. At the same time 
Michalopoulos et al. described hepatopoietin A, a 
growth factor of > 120 kDa, in rat serum and subse- 
quently in rabbit and human serum [5]. These three 
high molecular weight growth factors, hepatotropin, 
hepatocyte growth factor and hepatopoietin A, now 
appear to be the same substance and in this paper will 
be referred to as hepatotropin for simplicity. 
Hepatotropin has been recently purified and cloned, 
and its primary structure deduced from the nucleotide 
sequence [6,7]. A 6 kb mRNA for hepatotropin was 
identified in human liver [7]. A role for hepatotropin in 
hepatocyte regeneration after CC4 induced damage 
was indicated by expression of a similar 6-kb RNA in 
rat liver 10 h after induction of damage [7]. 
nucleotide sequence [6], to examine the expression of 
this RNA during regeneration after partial hepatectomy 
and during foetal development. Our results suggest a 
major role for hepatotropin in liver growth during em- 
bryonic development as well as in regeneration of adult 
liver after surgical and chemical injury. 
2. MATERIALS AND METHODS 
2.1, DNA probe preparation 
Two 20-mer oligonucleotides were synthesised on an Applied 
Biosystems oligonucleotide synthesizer, model 380B. Primer 
sequences were GCTTGGAATTCATGATGTCC and GCTGCAGA- 
CACACTTACTTC representing the ends of a 569 bp sequence from 
the hepatotropin cDNA which contained EcoRI and PstI restriction 
sites. mRNA from human liver was prepared by the method of 
Chirgwin et al. [8]. The polymerase chain reaction (PCR) was used to 
amplify RNA previously treated with reverse transcriptase (super RT, 
Anglian Biotechnology Ltd), with 30 cycles at annealing temperature 
of 60°C and Taq polymerase (Amplitaq, Perkin Elmer - Cetus). The 
PCR product was gel purified, ligated into Bluescribe plasmid 
(Stratagene, USA), cloned in E. coli TG2 bacteria. Plasmid DNA was 
purified utilizing caesium chloride ultracentrifugation. The PCR pro- 
duct was also cloned into Ml3 vectors in both orientations for sequen- 
cing of single stranded DNA; sequencing was achieved with the Taq 
polymerase Sequencing system (TAQuence, USB, Cleveland, OH, 
USA), 50 ng DNA were labelled with 50 pCi [32P]CTP (Amersham 
PB10202, 370 MBq/ml, 3000 Ci/mmol) using random primer labell- 
ing [9]. 
We have constructed a 569 bp probe for the C- 
terminal end of the P-chain, using the published 
2.2. RNA filter hybridization 
Correspondence address: C. Selden, Gastroenterology Unit, Depart- 
ment of Medicine, Royal Postgraduate Medical School, Du Cane Rd, 
London, WI2 ONN, UK 
Abbreviations: MOPS, 3-[N-morpholinol-propanesulphonic a id; 
20 x SSC, 3 M NaCl, 0.3 M sodium citrate 
RNA was prepared from human and rat liver by two methods, the 
guanidinium isothiocyanate/caesium chloride ultracentrifugation 
method of Chirgwin et al. [8] and the lauryl sarcosine/isopropanol/ 
phenol chloroform method of Chomcxynski et al. [lo]. All solutions 
were made up with diethylpyrocarbonate-treated water and auto- 
claved. All glassware was baked at 200°C overnight. Total RNA was 
quantified by optical density measurements at260 nm, assuming 1 ab- 
sorbance unit = 40 kg RNA/ml. The ratio of absorbance at 260:280 
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nm was also assessed. For rat liver samples this was 1.7 + 0.12 (SD), 
for human tissues it was 1.83 f 0.15 (SD). Samples of total RNA 
were resolved on 1.5% agarose gels containing 6% formaldehyde, at 
120 mA for 3 h, in a running buffer of 20 mM MOPS, 5 mM sodium 
acetate, 1 mM EDTA, pH 7.0. RNA was transferred onto 0.2 pm 
Biodyne A biosilon membrane in 20 x SSC for 24 h and was fixed on- 
to the nylon membrane by exposure to UV light at 254 nm for 12 min 
at a distance of 16 cm. Membranes were prehybridized for 15 min 
without probe and then hybridized with radiolabelled DNA overnight 
as described by Church and Gilbert [ll]. Low stringency hybridiza- 
tion conditions were 0.5 M sodium phosphate, pH 7.2, 1 mM EDTA, 
1% bovine serum albumin and 7% sodium dodecyl sulphate (SDS), at 
65°C using 2 x lo6 dpm labelled probe/ml hybridization buffer. 
High stringency hybridization was achieved in 0.2 M sodium 
phosphate and 15% formamide. Blots were washed at high stringency 
in 40 mM sodium phosphate, 1% SDS, 1 mM EDTA, at 65°C with 
several changes. The filters were exposed to pre-flashed Kodak 
X&R-5 film at - 70°C for up to 14d, using intensifying screens. 
2.3. Tissue samples 
Surgical specimens of adult human liver and specimens of foetal 
tissue obtained at termination of pregnancy, were studied with ap- 
proval from the Royal Postgraduate Medical School Ethics Commit- 
tee. Rat liver tissue was obtained under a Home Office licence 
(Animals - Scientific Procedures Act, 1986). Tissue was snap frozen 
and stored in liquid nitrogen until use. 70% partial hepatectomy was 
performed as described by Higgins and Anderson [12]. Rats were 
sacrificed at 15 min, 45 min, 2 h, 4 h, 10 h, 12 h and 24 h after surgery. 
Rats treated with carbon tetrachloride received a single dose of 75 
mg/kg body weight in olive oil by gavage, and were sacrificed 10 h 
later. 
3. RESULTS 
3.1. Double stranded 569 bp DNA probe 
The 569 bp cDNA probe was shown by DNA sequen- 
cing to be homologous to the C-terminal portion of the 
p-chain of human hepatotropin described by Miyazawa 
et al. [6], nucleotides 1640-2209, and to have minor se- 
quence differences from that described by Nakamura et 
al. [7]. 
3.2. Northern Blot RNA analysis 
RNA preparation from rat and human liver yielded 
intact total RNA using either the caesium chloride 
method or the Chomczynski method. In subsequent 
studies the Chomczynski technique was used since it 
was more appropriate for small samples. The 569 bp 
probe hybridized with an approximately 6 kb human 
liver RNA under high stringency conditions, confirm- 
ing the results of Nakamura using polyA + human liver 
mRNA, and also hybridized to a smaller, approximate- 
ly 4.8 kb, fragment. 
3.3. RNA expression in human adult and foetal tissue 
Fig. 1 shows the Northern blot analysis of adult 
human liver prepared from patients who underwent 
surgical procedures, and that of foetal human liver 
(16.2 weeks gestational age). The two RNA samples 
prepared from two adults show similar amounts of 6 kb 
RNA, but appear to show a size difference in the 
smaller fragment. At 16.2 weeks gestational age there is 
a marked increase in the expression of the 6 kb frag- 
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Fig. 1. Northern blot analysis of human liver RNA. 1, normal adult, 
2, adult liver removed at time of resection for tumour; 3, foetal 
human liver, 16.2 week gestational age. 8.54 pg total RNA in each 
lane. Autoradiograph exposure 6d, - 70°C. High stringency 
hybridization conditions as described in the text. 
ment, with proportionally less of the 4.8 kb fragment, 
as compared with adult human liver. 
We investigated the time course of hepatotropin 
RNA expression in 5 specimens of foetal human liver 
ranging from 7.6-19.5 weeks gestational age. In all 
specimens there was strikingly enhanced mRNA expres- 
sion compared to adult human liver (11 to 22-fold in- 
crease assessed by scanning densitometry of auto- 
radiographs of the 6 kb band) (Fig. 2). Foetal pancreas 
demonstrated similar levels to normal adult liver 
whereas in foetal kidney the 6 kb mRNA species was 
only just detectable. An integrity agarose gel of the 
RNA samples howed all the liver, kidney and pancreas 
samples to be intact with a 2: 1 ratio of 28: 18s RNA, but 
the RNA prepared from foetal spleen was considerably 
degraded; despite evidence of the 6 kb RNA in this sam- 
ple no conclusions could be drawn from splenic tissue. 
Ethidium bromide staining of integrity gels, performed 
in parallel, using equivalent concentrations of RNA 
determined by optical density at 260 nm demonstrated 
similar amounts of 28 and 18s fluorescence under 254 
nm UV light in each sample. By densitometric scanning 
of photographed gels, the coefficient of variation in 
fluorescence of 28s ribosomal RNA between samples 
was 0.3. 
3.4. RNA expression in rat liver 
Using this probe we were able to detect he expression 
of mRNA in normal rat liver. In RNA prepared from 
normal rat liver, and from animals sacrificed at 15 min, 
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Fig. Z.Northern blot analysis of human liver RNA. l-5 foetal human 
liver: 1, 7.6 wk gestational age; 2, 9.7 wk; 3, 12.6 wk; 4, 16.2 wk; 5, 
19.5 wk; 6, foetal kidney 17.6 wk; 7, foetal spleen; 8, foetal pancreas 
11.9 wk; 9, foetal pancreas 15.9 wk; 10, adult human liver. All lanes 
were loaded with 3.08 pg total RNA except 8 which had 0.87 pg. 
Autoradiograph exposure 14d, - 70°C. High stringency hybridiza- 
tion conditions. 
45 min, 2 h, 4 h, 10 h, 12 h and 24 h after partial 
hepatectomy, we studied the expression of the 6 kb 
mRNA. Maximum expression was observed 10 h after 
hepatectomy (Fig. 3), reaching a level at least lo-fold 
greater than that in normal rat liver (normal rat = 791 
integral densitometric units, 10 h posthepatectomy = 
abcdefgh 
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Fig. 3. Northern blot analysis of rat liver RNA. a, normal rat liver; 
b-g, liver after partial hepatectomy: b, 15 min; c, 45 min; d, 2 h; e, 
4 h; f, 10 h; g, 24 h; h = rat liver 10 h after CCL administration by 
gavage. 8.54 fig total RNA in each lane. Low stringency hybridization 
conditions as described in the text. Autoradiograph exposure 6d, 
- 70°C. 
8156 integral densitometric units, measured with a 
Joyce Loebl scanning densitometer). The earliest detec- 
table increase in expression occurred 2 h post hepatec- 
tomy; by 24 h the RNA expression was reduced to near 
resting levels. Measuring hepatotropin RNA expression 
in rat liver after carbon tetrachloride administration we 
confirmed the reported elevation in 10 h, only in- 
vestigating this time point. The level of expression was 
not as great as that seen after partial hepatectomy. The 
damaging effect of this high dose of CC14 was confirm- 
ed by substantial elevations of liver enzyme levels in 
plasma (alkaline phosphatase 780 IU/l, normal range 
30-130 IU/l: aspartate amino transferase 678 IU/I, nor- 
mal range 5-27 III/l). 
4. DISCUSSION 
This study reports enhanced expression of RNA for 
hepatotropin in human foetal liver. This implies for the 
first time that hepatotropin is involved in normal 
physiological iver growth during development, in addi- 
tion to its involvement in liver regeneration after injury, 
suggesting similar mechanisms may be involved during 
normal embryonic development and liver regeneration 
after damage. 
The previously reported evidence of hepatotropin 
mRNA expression in adult rat liver after damage 
followed the use of carbon tetrachloride. Kinoshita et 
al. demonstrated apeak at 10 h with persistent elevation 
of mRNA expression up to 24 h [ 131. We demonstrated 
enhanced expression of hepatotropin RNA in the liver 
after surgical partial hepatectomy. The peak expression 
was also at 10 h but had returned to near normal levels 
by 24 h. This difference may be due to more prolonged 
damage induced by carbon tetrachloride. The findings 
after partial hepatectomy also confirm that RNA ex- 
pression for this growth factor does not depend on ex- 
posure of liver cells to chemical injury. 
Analysis of the kinetics of hepatotropin mRNA ex- 
pression requires precise quantification of RNA; this is 
difficult since the recognised technique for quantitating 
changes in specific mRNA expression, by reference to 
expression of control ‘housekeeping’ genes, is not ap- 
plicable to regenerating liver [14-161, as the levels of ac- 
tin, tubulin, albumin etc. are altered during liver 
growth. 
Previous reports have not commented on the 
presence of a second RNA species at approximately 4.8 
kb in human liver, but this second mRNA is also evi- 
dent in the Northern blot analysis of placental polyA + 
RNA described by Miyazawa [6]. At present his second 
fragment has not been positively identified but it may 
be the product of a second related gene or could arise 
from alternative splicing of the hepatotropin gene. 
Studies are underway to clarify the importance of this 
smaller mRNA. 
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The exact source of hepatotropin synthesis is current- 
ly controversial. Recently Zarnegar et al. [17] developed 
antibodies to rabbit hepatopoietin A and studied its 
distribution in normal tissues from adult rabbits by im- 
munohistochemistry, confirming their findings by 
preparing hepatopoietin A from the tissues which were 
immunologically positive. They localized the activity to 
several organs, namely pancreas, brain, salivary glands 
and Brunners glands, but not to spleen, thymus or 
kidney, and notably not to the liver. These findings dif- 
fer from our results, measuring RNA expression rather 
than protein content, of hepatotropin RNA in normal 
adult human and rat liver, and from those of Kinoshita 
et al. who reported the expression of hepatotropin 
mRNA after carbon tetrachloride induced injury in the 
non-parenchymal cell population of the liver [ 131. 
Zarnegar et al.‘s immunohistochemical findings in nor- 
mal tissues might be explained by only low level 
transcription of hepatotropin mRNA in non- 
proliferating liver, resulting in protein levels undetec- 
table by this immunohistochemical technique. After 
partial hepatectomy the protein levels in the liver would 
increase as suggested by the increased mRNA expres- 
sion demonstrated here. 
Our results in foetal tissue also support a role for the 
liver as a major site for producing hepatotropin. The 
detectable expression in the foetal kidney, and levels 
similar to those of adult liver in foetal pancreas, predict 
a potential for hepatotropin synthesis in those organs. 
The results of this study indicate a major 
physiological role for this hepatotrophic factor, in vivo, 
both in liver regeneration and in developmental liver 
growth. Further experiments will define its role relative 
to other stimuli to hepatocyte proliferation such as 
Transforming growth factor a! and Heparin binding 
growth factor 1. 
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